scholarly article | Q13442814 |
P50 | author | Alessandro Sette | Q28324161 |
P2093 | author name string | J Sidney | |
H M Grey | |||
S Southwood | |||
C Oseroff | |||
M F del Guercio | |||
P2860 | cites work | Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry | Q30434686 |
Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. | Q30463850 | ||
Structure of peptides associated with class I and class II MHC molecules | Q30463866 | ||
Chemistry of peptide interactions with MHC proteins | Q36166773 | ||
Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules | Q36741865 | ||
Promiscuous and allele-specific anchors in HLA-DR-binding peptides | Q36765334 | ||
Solution binding of an antigenic peptide to a major histocompatibility complex class I molecule and the role of beta 2-microglobulin | Q36890441 | ||
Peptide binding to major histocompatibility complex molecules | Q40385485 | ||
Methods to study peptides associated with MHC class I molecules | Q40388533 | ||
Origin, structure and motifs of naturally processed MHC class II ligands | Q40388539 | ||
Defining rules for the peptide-MHC class II interaction | Q40388545 | ||
New methods to predict MHC-binding sequences within protein antigens | Q40404799 | ||
The three-dimensional structure of peptide-MHC complexes | Q40444937 | ||
MHC ligands and peptide motifs: first listing | Q40612811 | ||
MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation | Q40807437 | ||
The biochemistry and cell biology of antigen processing and presentation | Q40898211 | ||
Two distinct HLA-A*0101-specific submotifs illustrate alternative peptide binding modes | Q41142596 | ||
Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules | Q41230821 | ||
Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning | Q41417268 | ||
Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays | Q41450491 | ||
A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules | Q41489222 | ||
Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis | Q41675478 | ||
Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule | Q41714857 | ||
Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. | Q41725161 | ||
Empty MHC class I molecules come out in the cold | Q41725383 | ||
Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell Srfaces | Q41756841 | ||
The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides | Q42074920 | ||
Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. | Q43429538 | ||
Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells | Q43521293 | ||
Autologous peptides constitutively occupy the antigen binding site on Ia. | Q44907850 | ||
Antigen presentation. One size fits all. | Q46607798 | ||
A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules | Q47888189 | ||
Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. | Q52112638 | ||
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules | Q55042699 | ||
Isolation and characterization of antigen-la complexes involved in T cell recognition | Q57000170 | ||
P304 | page(s) | Unit 18.3 | |
P577 | publication date | 2001-05-01 | |
P1433 | published in | Current Protocols in Immunology | Q26867023 |
P1476 | title | Measurement of MHC/peptide interactions by gel filtration | |
P478 | volume | Chapter 18 |
Q27488347 | A Protective Role for Dengue Virus-Specific CD8+ T Cells |
Q24611383 | A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans |
Q36788055 | A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population |
Q28547607 | Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity |
Q37277042 | Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii |
Q34057942 | Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial |
Q35785418 | Automated benchmarking of peptide-MHC class I binding predictions |
Q34428561 | Broad and cross-clade CD4+ T-cell responses elicited by a DNA vaccine encoding highly conserved and promiscuous HIV-1 M-group consensus peptides |
Q42286141 | CD8+ T-cell epitope mapping for pneumonia virus of mice in H-2b mice |
Q40086895 | Dana-Farber repository for machine learning in immunology |
Q35840599 | Defining the herpes simplex virus-specific CD8+ T cell repertoire in C57BL/6 mice |
Q33557772 | Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo |
Q35839141 | Divergent Motifs but Overlapping Binding Repertoires of Six HLA-DQ Molecules Frequently Expressed in the Worldwide Human Population |
Q27679355 | Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire |
Q59337036 | Footprints of antigen processing boost MHC class II natural ligand predictions |
Q34744724 | Functional analysis of frequently expressed Chinese rhesus macaque MHC class I molecules Mamu-A1*02601 and Mamu-B*08301 reveals HLA-A2 and HLA-A3 supertypic specificities |
Q51759998 | Genome-based approaches to develop epitope-driven subunit vaccines against pathogens of infective endocarditis. |
Q47100879 | High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma |
Q34439215 | Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restri |
Q28752157 | IMMUNOCAT-a data management system for epitope mapping studies |
Q33851329 | Identification of CD4+ T cell epitopes in C. burnetii antigens targeted by antibody responses |
Q33956199 | Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans |
Q36886232 | Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen. |
Q35018972 | Identification of conserved and HLA promiscuous DENV3 T-cell epitopes |
Q30419031 | Identification of the peptide-binding motif recognized by the pigtail macaque class I MHC molecule Mane-A1*082:01 (Mane A*0301). |
Q36994720 | Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans |
Q35268996 | Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design |
Q35835769 | Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease |
Q89965526 | Major Histocompatibility Complex Binding, Eluted Ligands, and Immunogenicity: Benchmark Testing and Predictions |
Q42089275 | Major histocompatibility complex class II molecule-human immunodeficiency virus peptide analysis using a microarray chip |
Q38947679 | Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction |
Q37139374 | Mutated BCR-ABL generates immunogenic T-cell epitopes in CML patients |
Q33651342 | Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101. |
Q47696633 | NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data |
Q30413358 | Peptide-binding motifs associated with MHC molecules common in Chinese rhesus macaques are analogous to those of human HLA supertypes and include HLA-B27-like alleles |
Q37806810 | Prediction of epitopes using neural network based methods |
Q37346707 | Preventing tumor escape by targeting a post-proteasomal trimming independent epitope. |
Q30413827 | Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity |
Q24564623 | Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection |
Q37706396 | Spleen cells from young but not old immunized mice eradicate large established cancers |
Q34312500 | State of the art and challenges in sequence based T-cell epitope prediction |
Q27680213 | Structure-based design of altered MHC class II-restricted peptide ligands with heterogeneous immunogenicity |
Q33917224 | Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia |
Q28485408 | T-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifs |
Q37384380 | T-cell recognition of prostatic peptides in men with chronic prostatitis/chronic pelvic pain syndrome |
Q39725034 | The CD4+ T-cell epitope-binding register is a critical parameter when generating functional HLA-DR tetramers with promiscuous peptides |
Q36541082 | The identification of potentially pathogenic and therapeutic epitopes from common human allergens |
Q33931464 | The most common Chinese rhesus macaque MHC class I molecule shares peptide binding repertoire with the HLA-B7 supertype |
Q33952695 | The role of MHC class I allele Mamu-A*07 during SIV(mac)239 infection |
Q35634197 | Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice |
Q33459720 | Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity |
Q33676647 | Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection |
Search more.